|
Vyalov S.S., Gilyuk A.V.
Liver and biliary tract damage induced by SARS-CoV-2 coronavirus infection
|
№6 / 2022
|
|
Ostroumova O.D., Butorov V.N.
The use of nadroparin in clinical practice
|
№6 / 2022
|
|
Kheilo T.S., Danilogorskaya Yu.A., Gladysheva E.G., DjavatkhanovA M.R., Samorukova I.V., Snytko S.V.
Experience of using the domestic OKO capillaroscope for morphofunctional parameters of bulbar conjunctiva microvasculature assessment in various diseases
|
№6 / 2022
|
|
Tarzimanova A.I.
The significance of non-alcoholic fatty liver disease in atrial fibrillation development: view of cardiologist
|
№5 / 2022
|
|
Malyavin A.G., Gorelov A.V., Antonova E.A., Pobedinskaya T.A., Globenko А.А., Kapashin A.V., Bagaeva M.I.
Efficacy and safety evaluation of Ingavirin® as COVID-19 antiviral therapy: clinical trial
|
№5 / 2022
|
|
Lazebnik L.B.
Increasing the efficiency of eradication anti-Helicobacter therapy by combined pharmaceuticals set use
|
№5 / 2022
|
|
Resolution of the consensus of Russian Federation experts on the diagnosis and treatment of osteoarthritis for primary care physicians
|
№5 / 2022
|
|
Resolution of the Expert council «Herbal medicines with proven clinical efficacy in physician›s clinical practice»
|
№5 / 2022
|
|
Resolution of the Expert council «Dysbiosis. immediate and long-term consequences of microbiome disturbances and options for their correction with the help of probiotics» (from February 19, 2022)
|
№5 / 2022
|
|
Zaitsev A.A., Leshchenko I.V., Malyavin A.G.
Acute bronchitis – project of clinical guidelines
|
№5 / 2022
|
|
Babak S.L., Gorbunova M.V., Goruleva E.I., Malyavin A.G.
Nebulized budesonide in asthma exacerbations: rules of therapy in the COVID-19 era
|
№5 / 2022
|
|
Zyryanov S.K., Butranova O.I.
Effectiveness of including azoximer bromide in the standard management of ICU patients with severe COVID-19
|
№5 / 2022
|
Русский
